Nexalin Technology, Inc. (NXL)

NASDAQ: NXL · Real-Time Price · USD

0.3483

-0.0047 (-1.33%)

At close: Mar 31, 2026, 4:00 PM EDT

0.3603

+0.0120 (3.45%)

After-hours: Mar 31, 2026, 7:53 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Medical Products			110.75K	1.32M	144.07K	242.91K	207.38K
Medical Products Growth			-91.62%	817.20%	-40.69%	17.13%	-
Total			110.75K	1.32M	144.07K	242.91K	207.38K
Total Growth			-91.62%	817.20%	-40.69%	17.13%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States			107.13K	113.54K	117.93K	242.91K	207.38K
United States Growth			-5.64%	-3.72%	-51.45%	17.13%	-
China			3.61K	1.21M	26.13K	-	-
China Growth			-99.70%	4521.98%	-	-	-
Total			110.75K	1.32M	144.07K	242.91K	207.38K
Total Growth			-91.62%	817.20%	-40.69%	17.13%	-

Source: S&P Global Market Intelligence.